United States · FDA National Drug Code directory
Anastrozole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 87063-224_544d8a57-d527-c727-e063-6294a90a9794
- Product NDC
- 87063-224
- Form
- TABLET
- Composition / generic term
- Anastrozole Tablets
- Labeler
- ASCLEMED USA INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190228
- Source listing expiry
- 20271231
Source-listed ingredients
- ANASTROZOLE — 1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (87063-224-05) · 87063-224-05
- 30 TABLET in 1 BOTTLE (87063-224-30) · 87063-224-30
- 60 TABLET in 1 BOTTLE (87063-224-60) · 87063-224-60
- 90 TABLET in 1 BOTTLE (87063-224-90) · 87063-224-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →